About: drugs

Health 04-10-2017

Gastein boss: Drugs access is ‘sensitive’ and cannot be viewed in isolation

Accessibility of medicines is a sensitive issue that must not be examined in isolation. Policymakers, academics, business and patients must be part of the discussion as well as “innovation” because access would not get the focus it needs without it, according to Dorli Kahr-Gottlieb.
Health 11-07-2017

Dutch health minister: EMA relocation is not entertainment, listen to the Commission

The European Medicines Agency (EMA) is not a toy to be played with by politicians, Edith Schippers told EURACTIV.com. The decision on the agency's relocation should be based on the European Commission's assessment, she argues in an interview.
Health 14-03-2011

Pharma chief: Europe must not fall behind US, emerging countries

Brian Ager, Director-General of the European Federation of Pharmaceutical Industries and Associations (EFPIA), is leaving his position after 16 years at the head of the trade association. In an interview with EURACTIV, he reflects on his tenure and discusses some of the new legislation and controversies affecting the pharmaceutical industry.

Want to know what's going on in the EU Capitals daily? Subscribe now to our new 9am newsletter.